Industry Focus
One of the greatest challenges in healthcare today is maintaining healthy, safe indoor air throughout medical facilities. Hospitals, clinics, rehabilitation centers, nursing homes, continuing care facilities, and doctor’s offices must be kept safe for the health care providers, patients, staff, and visitors who gather in such spaces every day; monitoring and controlling indoor air quality is critical to stopping the spread of infection and reducing Healthcare-Acquired Infections (HAIs).

Patients in medical facilities not only introduce pathogens to those spaces, they also ingest pathogens – from fellow patients as well as doctors, nurses, and other professionals who visit multiple patients and areas throughout the day.

In addition, the circulation of air within the facilities themselves, if not properly monitored and controlled, can often enable rather than restrict the spread of disease.

It is critically important, therefore, to be able to continuously monitor the air quality inside each and every space within a medical facility, to understand the flow of air among spaces both interior and exterior, implement the right air change rates, and to be able to react quickly to the detection of any pathogens with the appropriate changes to ventilation control systems.

Only by monitoring and analyzing indoor air quality in real time, deriving insights quickly, and acting on those insights with the correct remediations, can health care facilities ensure highest indoor air quality standards and improve the safety and wellbeing of both healthcare providers and patients alike.

Real World Scenarios

Maximizing infection control and reducing HAI risk through continuous monitoring of C02 and particulate matter concentrations

Ensure compliance with CDC, ASHRAE and other regulations to mitigate risk and avoid penalties

Further Reading


Optimizing Health and Business Outcomes
Read More

Hospitals select TelosAir to minimize healthcare acquired infections (HAI) using air quality measurements

The Challenges Healthcare acquired infections (HAIs) place a significant economic and regulatory cost -estimated at $25B...